You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 143 No. 5, May 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Special Feature
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Surgery
 •Surgical Interventions
 •Gastrointestinal/ Upper Foregut
 •Surgical Oncology
 •Diagnosis
 •Computed Tomography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Image of the Month—Diagnosis


Arch Surg. 2008;143(5):512.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Answer: Retroperitoneal Extraskeletal Ewing Sarcoma

A computed tomographic–guided fine-needle aspiration biopsy specimen obtained from the lesion revealed small and round blue cells with round nuclei, small nucleoli, and scanty cytoplasm, which seemed to be well organized. Immunohistochemical analysis revealed intense staining for CD99, CAM 5.2, epithelial membrane antigen, and anti–cytokeratin antibodies AE1/AE3, and negative staining for FLI-1, desmin, and leukocyte common antigen.

Based on these findings, the diagnosis was consistent with an extraskeletal Ewing sarcoma (EES) or primitive neuroectodermal tumor.

In accordance with the oncologists, the patient received 2 cycles of neoadjuvant chemotherapy according to the CEVAIE regimen (carboplatin, etoposide phosphate, vincristine, actynomicin D, ifosfamide, and epirubicine hydrochloride). On restaging magnetic resonance imaging, significant tumor shrinkage was reported, with a maximum diameter of the lesion of 7.5 cm; the tumor continued to infiltrate the left renal parenchyma, left renal vascular structures, and left adrenal gland and involved the pancreatic tail.

At laparotomy (Figure 2. . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Image of the Month—Quiz Case
Fausto Rosa, Antonio Pio Tortorelli, Valerio Papa, Fabio Pacelli, and Giovanni Battista Doglietto
Arch Surg. 2008;143(5):511.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.